Author

Helmut Paul

Observed name: H Paul

Institution: Octapharma (Austria)

Observed institutions: IMC University of Applied Sciences Krems, Octapharma (Austria)

ORCID: 0000-0003-3217-4454

Observed ORCID: 0000-0003-3217-4454

OpenAlex ID: A5001840194

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A

2024 · Ilja Oomen, Marieke Verhagen, et al. · Frontiers in Immunology · 7

Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication

2022 · Helmut Paul, Verena Berg, et al. · Blood Advances · 7

Cytokine dynamics following joint injury in hemophilia A mice

2026 · O Oleshko, L Monica, et al. · Hämostaseologie

Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins

2025 · Lara Monica, Olga Oleshko, et al. · Research and Practice in Thrombosis and Haemostasis

Impact of secondary FVIII prophylaxis on joint bleeding and arthropathy in a Hemophilia A mouse model lacking inhibitor response

2025 · Lara Monica, Joyce Kimenai, et al. · Blood

Works count: 5

Citation count: 14

H-index: 2

I10-index: